Perigon Wealth Management
ONC icon

Perigon Wealth Management’s BeOne Medicines Ltd ONC Stock Holding History

Perigon Wealth Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$908K Sell
2,480
-71
-3% -$24.3K 0.01% 639
2026
Q2 		$727K Buy
2,551
+14
+0.6% +$4.12K 0.01% 709
2026
Q1 		$753K Buy
2,537
+39
+2% +$12.6K 0.01% 623
2025
Q4 		$759K Buy
2,498
+127
+5% +$41.6K 0.01% 629
2025
Q3 		$808K Sell
2,371
-29
-1% -$8.81K 0.02% 581
2025
Q2 		$581K Buy
2,400
+21
+0.9% +$5.15K 0.01% 626
2025
Q1 		$647K Buy
+2,379
New +$556K 0.02% 568

Other funds holding ONC

ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
Barings
Barings Charlotte, North Carolina $5.84B AUM 11.61% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return
Slow Capital
Slow Capital Greenbrae, California $890M AUM 40.96% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
TAA
TB Alternative Assets Grand Cayman, Cayman Islands $488M AUM 102.53% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return
WESPAC Advisors SoCal
WESPAC Advisors SoCal Pasadena, California $553M AUM 26.96% 1-Year Est. Return
Quadrant Capital Group
Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return

Perigon Wealth Management's ONC Position: Q3 2026 in Review

Perigon Wealth Management reduced its BeOne Medicines Ltd (ONC) stake by 2.8% in Q3 2026, selling an estimated $24.3K and leaving 2,480 shares worth $908K. The position accounts for 0.01% of the portfolio, ranked #639.

Perigon Wealth Management first reported a position in ONC in Q1 2025 and has held it in 7 quarters since. 61 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Perigon Wealth Management held 2,480 shares of BeOne Medicines Ltd worth $908K as of Q3 2026.
  • Perigon Wealth Management sold 71 BeOne Medicines Ltd shares in Q3 2026, an estimated $24.3K.
  • BeOne Medicines Ltd made up 0.01% of Perigon Wealth Management's portfolio in Q3 2026, its #639 holding.
  • Perigon Wealth Management first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 7 quarters since.
  • 61 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on Perigon Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.